Jesús Alberto Escarpa Miguel

Jesús Alberto Escarpa Miguel is a Professor in the Department of Analytical Chemistry, Physical Chemistry and Chemical Engineering at the University of Alcalá (UAH), Spain. He coordinates the Miniaturization and Analytical Nanotechnology research group, developing cutting-edge analytical tools for clinical diagnostics, forensic science, and food analysis.

His research centers on nanotechnology-driven solutions for real-world diagnostic challenges. Key focus areas include electrochemical biosensors, microfluidic paper-based devices, and catalytic micromotors for point-of-care applications. His work bridges fundamental nanomaterial science with practical clinical tools, particularly for sepsis diagnosis, Alzheimer's biomarker detection, and food safety analysis. The lab emphasizes cost-effective, rapid testing solutions deployable in resource-limited settings.

Recent publications reveal a strong trend toward clinical translation of micro/nanotechnologies. His team integrates micromotors with electrochemical detection for biomarker quantification in complex samples like blood and urine, while advancing paper-based platforms for smartphone-connected diagnostics. This work spans from nanomaterial synthesis to FDA-relevant clinical validation studies.

Professor Escarpa Miguel actively secures competitive research funding, currently leading two major projects (2024-2027) totaling over 377,000€ from Spanish national and regional agencies. His lab provides students with hands-on experience in sensor fabrication, microfluidics, and clinical validation, fostering translation of academic research into practical diagnostic tools through strong industry and hospital partnerships.

The Miniaturization and Analytical Nanotechnology group operates state-of-the-art facilities including electrochemical workstations, microfabrication tools, and clinical sample processing equipment. The lab culture emphasizes interdisciplinary collaboration between chemists, engineers, and clinicians to develop diagnostics meeting real clinical needs, with current projects targeting neonatal sepsis, neurodegenerative diseases, and food contaminant detection.